News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Skinvisible, Inc. (SKVI) Announces Canadian License Agreement with Alto Pharmaceuticals for DermSafe



12/9/2009 8:20:25 AM

LAS VEGAS, Dec. 9, 2009 (GLOBE NEWSWIRE) -- Skinvisible, Inc. (OTCBB:SKVI) and Alto Pharmaceuticals (www.altopharma.com), a dermatology-focused company based in Toronto, announced today they have entered into a license agreement for DermSafe(R), Skinvisible's antimicrobial hand sanitizer lotion that recently completed clinical studies proving it kills the H1N1 virus. Under the terms of the agreement, Alto will pay Skinvisible an upfront license fee for the exclusive manufacturing and the commercial / professional use marketing rights for DermSafe in Canada. Skinvisible will also receive a royalty from product sales.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES